Ruben Mars

Microbiologist and metabolomics specialist, Assistant Professor Mayo Clinic, passionate about microbiome therapeutics & personalized preventive health

[Tiny Health @GetTinyHealth]

We don't make the results, we just report them!

We're glad @_katetolo's doing so well. 🧬 And yes, we do have a test for that. https://t.co/6QqjtfZHUV

[Tiny Health @GetTinyHealth]

Top 1% of all vaginas tested!

This is a real Tiny Health vaginal microbiome report.

L. crispatus at 98.7% is linked to lower risk of BV, UTIs, yeast infections, and better fertility outcomes.

[Ruben Mars @rubenmars]

@mezooterxbt @bryan_johnson https://t.co/6ByRytjZr0

[Ruben Mars @rubenmars]

@lialiascg @bryan_johnson https://t.co/6ByRytjZr0

[Ruben Mars @rubenmars]

@NinthHouseFemme @bryan_johnson https://t.co/6ByRytjZr0

[Ruben Mars @rubenmars]

@skip_super @bryan_johnson https://t.co/6ByRytjZr0

[Mayo Clinic Gastroenterology & Hepatology @MayoClinicGIHep]

Microbiome science is poised to redefine cancer care- but only if we move beyond correlations.

The future lies in:
🎯Mechanistic precision

💻AI-guided interventions

🌎Real-world clinical validation to deliver more effective and tolerable cancer therapies.

Check out more below from @KashyapPurna 's recent publication! ⬇️
https://t.co/y8jaEjUbV3

#Mircobiome #GI #Excellence

[Nature Reviews Microbiology @NatureRevMicro]

New online! Harnessing the microbiome for cancer therapy https://t.co/XNp9dNeEBb

[Mayo Clinic Gastroenterology & Hepatology @MayoClinicGIHep]

Using a reverse translation approach, @KashyapPurna and team identified a previously unrecognized role for the small intestinal microbiome and a specific microbial member in driving abdominal pain, a common and debilitating gastrointestinal symptom.

Learn more about their findings in the publication below! @jclinicalinvest

https://t.co/UaY8Dx5VM6

#research #innovation

[Ruben Mars @rubenmars]

Full paper: https://t.co/GLteWpALEO

[Ruben Mars @rubenmars]

An exciting step for Tiny Health publishing their first randomized controlled trial on C-section infants:

In response to the intervention program not only a dramatic shift in the gut microbiome was seen but even a reduced incidence of atopic conditions in the first year of life.

[Ruben Mars @rubenmars]

@nic_carter Check out https://t.co/xMoJA5VqJu

[Ruben Mars @rubenmars]

@bryan_johnson What water test do you recommend?

[Ruben Mars @rubenmars]

@bryan_johnson How are you assessing your microbiome? There are a lot issues with most tests.

[Cheryl (Yeoh) Sew Hoy @cherylyeoh]

Today, I’m thrilled to announce our $8.5 million Series A round led by @SperoVentures, alongside partners @OverwaterVC, @nextcoastVP, @PetersonVenture, Modi Ventures, Tamarisc Ventures, @Cartancapital, and Taylor Sittler, Co-founder of @Color. https://t.co/Cah1OXtVOY

[Ruben Mars @rubenmars]

@GetTinyHealth So true!

[Purna Kashyap M.B.B.S., AGAF @KashyapPurna]

Our review now online @AGA_Gastro @rubenmars outlines current approaches & gaps and provides roadmap for accelerating translation of #gutmicrobiome science towards precision therapies in #FGID like #IBS. integrated #multiomics #AI longitudinal studies https://t.co/BnXX3Cxv0o

[Purna Kashyap M.B.B.S., AGAF @KashyapPurna]

Check out our paper in @iScience_CP on role of bacterially derived tryptamine in mucus release from goblet cells and sex-dependent attenuation of inflammatory response to DSS #IBD @MayoClinicCIM @MayoClinicGIHep @mfgrp @GutBugs2 @rubenmars @GFarrugiaMD https://t.co/UtkYb5ShBz

[GutMicrobiota Health @GMFHx]

What is the best strategy for moving microbiome-based therapies for functional gastrointestinal disorders such IBS into the clinic? @rubenmars, Frith & @KashyapPurna updates major challenges in this field via @AGA_Gastro https://t.co/lvxirt373G

[Tonya Ward @T_L_Ward]

Ever wonder why longitudinal studies in the microbiome are important? You can find signals otherwise lost in noise! https://t.co/FtWCcibDjP